Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2014122520434N1Phase 2Completed
Phase 2 trial of tranexamic acid and dexmedetomidine in None (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2014122520434N1.